Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Conteltinib |
Trade Name | |
Synonyms | CT-707|CT 707 |
Drug Descriptions |
Conteltinib (CT-707) is a kinase inhibitor of FAK (PTK2), PYK2 (PTK2B), ALK, and YAP1 (PMID: 29669759), which may result in antitumor activity including inhibition of both tumor growth and metastasis (PMID: 27638856, PMID: 30381078). |
DrugClasses | ALK Inhibitor 32 FAK inhibitor 15 YAP Inhibitor 3 |
CAS Registry Number | 1384860-29-0 |
NCIT ID | C126648 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cabozantinib + Conteltinib | Cabozantinib Conteltinib | 0 | 0 |
Conteltinib | Conteltinib | 8 | 0 |
Conteltinib + PHA-665752 | Conteltinib PHA-665752 | 0 | 0 |